A popular combo of a long-acting GHRH analog and a selective ghrelin-mimetic GH secretagogue, used to stimulate the body's own GH release; limited human efficacy data.
Complementary pathways: CJC-1295 binds pituitary GHRH receptors (cAMP) with a long half-life that raises GH-pulse amplitude; Ipamorelin binds the GHS-R1a ghrelin receptor (calcium-dependent) adding pulse strength with minimal cortisol/prolactin. Together they produce synergistic GH release.
Bars reflect the strength & volume of research evidence for each use — not a guarantee of results.
No reviews yet. If you've used CJC-1295 / Ipamorelin, be the first to share what it helped with and any side effects.
⚠️ Educational research information only — not medical advice. Many peptides are sold strictly for laboratory research and are not approved treatments. The evidence scores reflect research interest and strength, not efficacy or safety for any individual. Always consult a qualified professional.